Overview

• U.S. PCE inflation rose 0.3% in August and 2.7% year on year, in line with expectations, keeping prospects for further Fed easing intact as Treasury yields dipped and U.S. stocks opened higher.
• Fed voices remained split, with Michelle Bowman saying she expects two more rate cuts this year while other officials urged caution and Richmond’s Thomas Barkin flagged balanced risks to inflation and employment.
• President Donald Trump set a 100% surcharge on certain pharmaceutical imports starting October 1, alongside new levies on trucks, cabinets and sinks, and upholstered furniture, pressuring pharma shares in Asia and Europe.
• Brazil’s central bank lowered its 2026 GDP growth projection to 1.5%, reinforcing signs of cooling activity as local interest‑rate futures eased and investors monitored potential policy signals.
• Braskem hired financial and legal advisers to review options for optimizing its capital structure, sending its shares sharply lower into auction trading and restraining the Ibovespa’s early gains.